信息搜索
信息关键字：实
  

共有4831条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242]

·中实能源总经理任大俊辞职2021年公司亏损66.45万2022-7-27 17:34:11
·上峰水泥：公司光伏储能项目正在积极推进实施中暂未贡献利润2022-7-27 16:36:48
·华统股份半年回顾：业绩好转仍亏损，实控人被警示2022-7-27 16:24:58
·三五互联4年亏7亿企业邮箱市场份额仅1%原实控人龚少晖近99%股份质押并均已到期2022-7-27 13:49:47
·实控人刚取保又被监视居住华宝股份、华宝国际双双大跌2022-7-27 13:45:30
·犯啥事？前脚“出”后脚“进”华宝股份实控人被江西警方监视居住2022-7-27 13:34:50
·首次证券公司投资者教育工作评估顺利实施2022-7-27 10:05:50
·药明康德：上半年实现净利润46.36亿元，同比增长73.29%2022-7-26 17:44:27
·三五互联提示原实控人持股存在平仓风险2022-7-26 10:56:09
·新华制药回应与真实生物的合作进展情况：不存在应披露而未披露的重大事项2022-7-26 9:41:01
·业内重磅！复星医药牵手真实生物，联合开发及独家商业化阿兹夫定2022-7-26 9:11:19
·原实控人债务逾期持股或被强平、司法拍卖！公司控制权或发生变更2022-7-26 8:58:29
·利用漏洞拖延回复？监管层亮剑，实质性提高审核效率，保荐人“缓兵之计”行不通了！2022-7-26 8:45:42
·【早盘内参】能源局：大力推动油气相关规划落地实施2022-7-26 5:41:20
·首个国产新冠口服药花落真实生物：疗效如何？谁将紧随其后？2022-7-26 2:28:36
·21CC肿瘤情报（第16期）：靶向ADC药物Enhertu在欧盟获批；君实生物特瑞普利单抗获欧盟委员会孤儿药资格认定2022-7-25 21:27:31
·江西国控回应“网传一员工在朋友圈炫富秀权”：正在核实2022-7-25 20:28:32
·日盈电子实际控制人是蓉珠增持100万股2022年第一季度公司净利332.2万2022-7-25 19:51:53
·日本内阁府将本财年GDP实际增长预期下调至2%左右-财经2022-7-25 18:48:00
·水治理北交所上市审查终止：被问询收入核算真实准确性与市场竞争力2022-7-25 17:40:56

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242]